Phibro Animal Health Corporation (PAHC) vs Xeris Biopharma Holdings, Inc. (XERS)

Phibro Animal Health Corporation and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Xeris Biopharma Holdings, Inc. is the larger, with a market value of $1.6B against $1.4B — 1.2× the size. Xeris Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Phibro Animal Health Corporation trades at 14.0×. Xeris Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 36.3% against 17.1%. Phibro Animal Health Corporation has the higher net margin (6.57% vs −5.12%) and the lower return on invested capital (11.7% vs 18.9%). Across the 20 metrics below, Phibro Animal Health Corporation leads on 11 and Xeris Biopharma Holdings, Inc. on 9.